DuoNeb is a prescription drug approved by the Food and Drug Administration (FDA) to treat bronchospasm in people with chronic obstructive pulmonary disease (COPD) who need more than one bronchodilator. DuoNeb is a combination drug composed of Ipratropium and Albuterol.
Both Ipratropium and Albuterol are short-acting bronchodilators, or drugs that dilate the bronchi and bronchioles in the lungs. Ipratropium is an anticholinergic, while Albuterol is a beta2-adrenergic agonist. Both drugs are believed to work by relaxing and dilating the airways, making it easier to breathe.
How do I take it?
DuoNeb is taken four to six times a day by nebulizer.
DuoNeb comes in single-dose vials.
The FDA-approved label for DuoNeb lists common side effects including headache, dizziness, nervousness, dry mouth, cold symptoms, shaking, nausea, and dry mouth.
Rare but serious side effects listed for DuoNeb can include cardiovascular effects, hypersensitivity reactions, and paradoxical bronchospasm (bronchospasm caused by taking medication).
For more details about this treatment, visit:
DuoNeb – RxList
We never share your personal information with anyone.